ARC RESEARCH INSTITUTE: Form 990, tax year 2024
View the entire original 990 at ProPublica ↗
- Organization
- ARC RESEARCH INSTITUTE (EIN 87-1920284)
- Tax period
- 2024-01-01 to 2024-12-31
- Filed
- 2025-11-11
- IRS object ID
- 202513159349306771
- Schema version
- 2024v5.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2025-11-11T20:32:58+00:00 | ReturnTs |
| Tax Period End | 2024-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 350921680 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CROWE LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 575 Market Street Suite 3300 | AddressLine1Txt |
| City | San Francisco | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 941055829 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2024-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 871920284 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Arc Research Institute | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | ARCR | BusinessNameControlTxt |
| Phone | 6508994880 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3181 Porter Dr | AddressLine1Txt |
| City | Palo Alto | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 943041249 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | SILVANA M KONERMANN | PersonNm |
| Person Title | EXECUTIVE DIRECTOR | PersonTitleTxt |
| Phone | 6508994880 | PhoneNum |
| Signature | 2025-11-12 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | Diane Kirmaci | PreparerPersonNm |
| PTIN | P01578407 | PTIN |
| Phone | 4155761100 | PhoneNum |
| Preparation | 2025-11-12 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2024 | TaxYr |
| Build TS | 2025-03-06 01:10:19Z | BuildTS |
Form 990 IRS990
Principal Ofcr Business Name PrincipalOfcrBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | SILVANA M KONERMANN PHD | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3181 Porter Dr | AddressLine1Txt |
| City | Palo Alto | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 943041249 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $122,280,682 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | https://arcinstitute.org/ | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2021 | FormationYr |
| Legal Domicile State | DE | LegalDomicileStateCd |
| Activity Or Mission | Our mission is to accelerate scientific progress and understand the root causes of complex diseases. This challenge requires researchers across many disciplines to study fundamental biological mechanisms, develop new technologies, and innovate on therapeutic concepts. By doing this, we aim to improve human health by narrowing the gap between discoveries and impact on patients. | ActivityOrMissionDesc |
| Voting Members Governing Body | 3 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 3 | VotingMembersIndependentCnt |
| Total Employee | 155 | TotalEmployeeCnt |
| Total Volunteers | 12 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| PY Contributions Grants | $52,978,731 | PYContributionsGrantsAmt |
| CY Contributions Grants | $120,446,690 | CYContributionsGrantsAmt |
| CY Program Service Revenue | $166,647 | CYProgramServiceRevenueAmt |
| PY Investment Income | $632,713 | PYInvestmentIncomeAmt |
| CY Investment Income | $1,667,345 | CYInvestmentIncomeAmt |
| CY Other Revenue | $0 | CYOtherRevenueAmt |
| PY Total Revenue | $53,611,444 | PYTotalRevenueAmt |
| CY Total Revenue | $122,280,682 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $8,572,720 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $11,262,833 | CYGrantsAndSimilarPaidAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $16,259,942 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $24,229,467 | CYSalariesCompEmpBnftPaidAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $39,371,036 | PYOtherExpensesAmt |
| CY Other Expenses | $47,289,556 | CYOtherExpensesAmt |
| PY Total Expenses | $64,203,698 | PYTotalExpensesAmt |
| CY Total Expenses | $82,781,856 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$10,592,254 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $39,498,826 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $155,698,196 | TotalAssetsBOYAmt |
| Total Assets EOY | $184,388,461 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $93,814,180 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $83,668,141 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $61,884,016 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $100,720,320 | NetAssetsOrFundBalancesEOYAmt |
| Mission | Our mission is to accelerate scientific progress, understand the root causes of disease, and narrow the gap between discoveries and impact on patients. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $64,083,480 | ExpenseAmt |
| Grant | $11,262,833 | GrantAmt |
| Revenue | $166,647 | RevenueAmt |
| Desc | - Core Investigators (which include the following labs) are provided with no-strings-attached, multi-year funding as well as cutting-edge scientific and infrastructure support to enable high-risk, high-reward science. They are innovative pioneers enabled to pursue their very best ideas. The Gilbert lab has an expertise in synthetic biology, functional genomics and cancer biology. We build CRISPR epigenetic editing tools to turn genes on and off and to perturb gene regulatory elements. We are developing CRISPR functional genomics approaches to map individual genes or sets of genes that regulate phenotypes of interest in vitro and in vivo. We are focused on utilizing our expertise to tackle big problems in deadly human cancers such as metastasis and drug resistance. The Hsu Lab works at the intersection of synthetic biology and genomics to invent new biotechnologies for improving human health. The Konermann lab develops and applies next-generation functional genomics to understand the cellular and molecular pathways underlying the neuronal system and neurodegenerative disease, with the long-term goal of developing rationally targeted therapeutics for neurodegenerative disorders. The Li Lab combines chemistry, biochemistry, immunology, and physiology to uncover basic mechanisms in innate immunity and, in parallel, develop therapeutic hypotheses and lead molecules. Innate immune pathways as the first line of defense against pathogens present many exciting opportunities for scientists from many disciplines. These pathways are a rich source of novel chemistry: they involve diverse molecular patterns in pathogens, little-explored second messengers, and drugs with poorly understood mechanism. Activation of innate immunity is a proven therapeutic strategy for vaccination, viral infection, and cancer, while inhibition is a strategy for treating autoimmune diseases and neurodegeneration. To date, however, most modulators of innate immunity are broad, non-specific, and poorly characterized, such as killed bacteria, alum crystals, and steroids. The Li lab seeks to improve understanding of these pathways and facilitate the development of more precise drugs for preventing or treating specific diseases. The Horns Lab creates and uses new technologies to understand and manipulate cells. We aim to discover the fundamental principles governing how cells and tissues operate, and to harness these insights to improve human health. Our work unites molecular engineering, synthetic biology, and genomics to answer questions and solve problems in immunology, neuroscience, cancer, and aging. The Goodarzi Lab combines modern experimental and computational technologies to understand complex human diseases at a molecular level. We are predominantly focused on metastatic progression in multiple cancers and neurodegenerative diseases as the biggest challenges to human health in the 21st century. - Technology Development Centers As biomedical research has become more advanced, it has become more dependent on complicated tooling that is difficult or impossible for any single lab to pursue today. Arc Technology Centers are focused on advancing and distributing key biomedical technologies within the institute that require high capital scale, targeted expertise, and systematic innovation. Our Technology Centers provide long-term career options for Arc scientists beyond their training period. By enabling competitive compensation relative to the biotech and tech industries (such as for research scientists and computer programmers), our goal is to expand the ecosystem of available career paths in research and maintain continuity in critical technical know-how. We have 5 staffed Technology Centers focused on 1. Cellular Models 2. Genome Engineering 3. Mammalian Models 4. Multi-omics 5. Computational biology - Translational Programs Making an impact on complex diseases requires new fundamental biological insights into disease mechanisms and new technologies that can target rational therapeutic pathways at the right place and time in the body. In addition to curiosity-driven knowledge building, producing medically useful discoveries is a core mission of Arc. Arc will build translational infrastructure to support the distribution of new biological insights and biotechnologies into the clinical environment. This branch of the institute will be dedicated to reducing the friction of transferring academic research into for-profit spin-outs. This includes a streamlined IP licensing process, funding support, and an advisory network of drug development and domain experts. We will also create focused, entrepreneurial teams dedicated to testing specific ideas, such as a new gene target or effector molecule, within the institute. Our goal is to empower Arc scientists, engineers, and inventors to accelerate their work into impact on patients. | Desc |
| Total Program Service Expenses | $64,083,480 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | false | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | false | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | Yes (true) | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | false | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | false | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Escrow Account | false | EscrowAccountInd |
| On Behalf Of Issuer | false | OnBehalfOfIssuerInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | false | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | Yes (true) | DisregardedEntityInd |
| Related Entity | false | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | false | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 44 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 155 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | Yes (true) | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 3 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 3 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (true) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (true) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | false | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Policies Reference Chapters | false | PoliciesReferenceChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | false | CompensationProcessCEOInd |
| Compensation Process Other | false | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| Written Policy Or Procedure | false | WrittenPolicyOrProcedureInd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Michael Teng | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 2029425355 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3181 Porter Dr | AddressLine1Txt |
| City | Palo Alto | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 943041249 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (20 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| Nathaniel Friedman | ||||||||
| Director | 1.0 | 0.0 | Yes (X) | $36,000 | $0 | $0 | ||
| Reid Hoffman | ||||||||
| Director | 1.0 | 0.0 | Yes (X) | $36,000 | $0 | $0 | ||
| Susan Li | ||||||||
| Director | 1.0 | 0.0 | Yes (X) | $36,000 | $0 | $0 | ||
| Alden J Woodrow | ||||||||
| CHIEF OPERATING OFFICER | 40.0 | 0.0 | $1,141,800 | $0 | $75,116 | Yes (X) | ||
| Daniel P Dever PhD | ||||||||
| Head of Scientific Operations (until 1/26/24) | 40.0 | 0.0 | $62,998 | $0 | $5,760 | Yes (X) | ||
| Dave Burke | ||||||||
| Chief Technology Officer (as of 10/31/2024) | 40.0 | 0.0 | $65,712 | $0 | $10,401 | Yes (X) | ||
| Julia M Kazaks | ||||||||
| GENERAL COUNSEL/ SECRETARY | 40.0 | 0.0 | $478,739 | $0 | $71,128 | Yes (X) | ||
| Lynn M Hendrickson | ||||||||
| UNIVERSITY RELATIONS & ACADEMIC AFFAIRS/ COMPLIANCE OFFICER | 40.0 | 0.0 | $344,044 | $0 | $74,771 | Yes (X) | ||
| Michael K Teng | ||||||||
| HEAD OF FINANCE/ TREASURER (AS OF 7/01/2024) | 40.0 | 0.0 | $151,006 | $0 | $37,111 | Yes (X) | ||
| Nicolle D Seuss | ||||||||
| Senior Operations Program Manager | 40.0 | 0.0 | $290,334 | $0 | $52,106 | Yes (X) | ||
| Patrick D Hsu PhD | ||||||||
| Core Investigator/ Co-Founder | 40.0 | 0.0 | $489,195 | $0 | $39,441 | Yes (X) | ||
| Rose E Harris | ||||||||
| Finance (until 7/15/24) | 40.0 | 0.0 | $127,201 | $0 | $262 | Yes (X) | ||
| Silvana M Konermann PhD | ||||||||
| EXECUTIVE DIRECTOR/ PRESIDENT | 40.0 | 0.0 | $245,574 | $0 | $18,972 | Yes (X) | ||
| Susan T Cull | ||||||||
| SENIOR FINANCE MANAGER | 40.0 | 0.0 | $189,233 | $0 | $9,893 | Yes (X) | ||
| Therese A Costello | ||||||||
| Head of People | 40.0 | 0.0 | $352,151 | $0 | $7,913 | Yes (X) | ||
| Hani Goodarzi PHD | ||||||||
| CORE INVESTIGATOR | 40.0 | 0.0 | $273,663 | $0 | $46,901 | Yes (X) | ||
| Lingyin Li PHD | ||||||||
| Core Investigator | 40.0 | 0.0 | $333,725 | $0 | $24,081 | Yes (X) | ||
| Luke A Gilbert PHD | ||||||||
| CORE INVESTIGATOR | 40.0 | 0.0 | $262,408 | $0 | $32,129 | Yes (X) | ||
| Nianzhen Li PHD | ||||||||
| Senior Director, Multi-omics technology development | 40.0 | 0.0 | $391,440 | $0 | $8,602 | Yes (X) | ||
| Yusuf H Roohani PHD | ||||||||
| Group lead, machine learning | 40.0 | 0.0 | $407,429 | $0 | $37,342 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $5,714,652 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $551,929 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 77 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | Address Line2ContractorAddress/USAddress/AddressLine2Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|---|
| Pulse One | ||||||
| 290 Maple Court | Suite 168 | Ventura | CA | 93003 | Consulting | $1,314,517 |
| WilmerHale | ||||||
| 3040 Newmark Drive | Miamisburg | OH | 45342 | Legal Services | $371,768 | |
| Milltown Partners LP | ||||||
| 550 Montgomery Street | Suite 750 | San Francisco | CA | 94111 | Marketing | $329,890 |
| Arnold & Porter Kaye Scholer LLP | ||||||
| PO Box 759451 | Philadelphia | PA | 191719451 | Legal Services | $267,843 | |
| INNOVIVE LLC | ||||||
| 10019 Waples Court | San Diego | CA | 92121 | Consulting | $218,577 | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 9 | CntrctRcvdGreaterThan100KCnt |
| All Other Contributions | $120,446,690 | AllOtherContributionsAmt |
| Total Contributions | $120,446,690 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | Sponsored Research | Desc |
| Business | 541700 | BusinessCd |
| Total Revenue Column | $166,647 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $166,647 | RelatedOrExemptFuncIncomeAmt |
Total Oth Program Service Rev TotalOthProgramServiceRevGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $166,647 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,667,345 | TotalRevenueColumnAmt |
| Exclusion | $1,667,345 | ExclusionAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $0 | SecuritiesAmt |
| Other | $0 | OtherAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Miscellaneous Revenue MiscellaneousRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $0 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $122,280,682 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $166,647 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $1,667,345 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $11,262,833 | TotalAmt |
| Program Services | $11,262,833 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,448,861 | TotalAmt |
| Program Services | $2,904,945 | ProgramServicesAmt |
| Management And General | $1,543,916 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,997,400 | TotalAmt |
| Program Services | $10,445,724 | ProgramServicesAmt |
| Management And General | $5,551,676 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $623,612 | TotalAmt |
| Program Services | $407,196 | ProgramServicesAmt |
| Management And General | $216,416 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,905,667 | TotalAmt |
| Program Services | $1,424,858 | ProgramServicesAmt |
| Management And General | $480,809 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,253,927 | TotalAmt |
| Program Services | $895,434 | ProgramServicesAmt |
| Management And General | $358,493 | ManagementAndGeneralAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $168,577 | TotalAmt |
| Program Services | $151,719 | ProgramServicesAmt |
| Management And General | $16,858 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,099,139 | TotalAmt |
| Program Services | $209,966 | ProgramServicesAmt |
| Management And General | $889,173 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $73,383 | TotalAmt |
| Management And General | $73,383 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,754,051 | TotalAmt |
| Program Services | $372,626 | ProgramServicesAmt |
| Management And General | $2,381,425 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $38,938 | TotalAmt |
| Program Services | $3,910 | ProgramServicesAmt |
| Management And General | $35,028 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $915,719 | TotalAmt |
| Program Services | $403,476 | ProgramServicesAmt |
| Management And General | $512,243 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,373,698 | TotalAmt |
| Program Services | $13,849,690 | ProgramServicesAmt |
| Management And General | $1,524,008 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $580,682 | TotalAmt |
| Program Services | $379,155 | ProgramServicesAmt |
| Management And General | $201,527 | ManagementAndGeneralAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $276,916 | TotalAmt |
| Program Services | $43,811 | ProgramServicesAmt |
| Management And General | $233,105 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $10,104,678 | TotalAmt |
| Program Services | $7,126,564 | ProgramServicesAmt |
| Management And General | $2,978,114 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $87,263 | TotalAmt |
| Management And General | $87,263 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| Lab expenses | $10,235,600 | $10,133,676 | $101,924 |
| Subscriptions | $2,158,958 | $1,486,550 | $672,408 |
| Student Expenses | $1,660,551 | $1,660,551 | |
| Health and safety expenses | $164,638 | $164,638 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,596,765 | TotalAmt |
| Program Services | $756,158 | ProgramServicesAmt |
| Management And General | $840,607 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $82,781,856 | TotalAmt |
| Program Services | $64,083,480 | ProgramServicesAmt |
| Management And General | $18,698,376 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,091,658 | BOYAmt |
| EOY | $7,617,326 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $618,831 | BOYAmt |
| EOY | $35,705,534 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,564 | BOYAmt |
| EOY | $238,439 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,232,853 | BOYAmt |
| EOY | $2,931,957 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $105,098,012 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $18,721,055 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $90,883,127 | BOYAmt |
| EOY | $86,376,957 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,000,000 | BOYAmt |
| EOY | $1,000,000 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $57,865,163 | BOYAmt |
| EOY | $50,518,248 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $155,698,196 | BOYAmt |
| EOY | $184,388,461 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,494,900 | BOYAmt |
| EOY | $10,583,375 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $16,080,816 | BOYAmt |
| EOY | $14,444,510 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $66,238,464 | BOYAmt |
| EOY | $58,640,256 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $93,814,180 | BOYAmt |
| EOY | $83,668,141 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $61,884,016 | BOYAmt |
| EOY | $100,720,320 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $61,884,016 | BOYAmt |
| EOY | $100,720,320 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $155,698,196 | BOYAmt |
| EOY | $184,388,461 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $39,498,826 | ReconcilationRevenueExpnssAmt |
| Prior Period Adjustments | -$1 | PriorPeriodAdjustmentsAmt |
| Other Changes In Net Assets | -$662,521 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Medical Research Organization | Yes (X) | MedicalResearchOrganizationInd |
Hospital Name And Address HospitalNameAndAddressGrp
Supported Organization Name SupportedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | See Part VI | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| City | See Part VI | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
Form990 Schedule A Part VI Form990ScheduleAPartVIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule A, Part I Hospitals | FormAndLineReferenceDesc |
| Explanation | The Institute is a medical research organization that operates in conjunction with Stanford (including its school of medicine and hospital system), UCSF (including its school of medicine and hospital system), and UC Berkeley. The Institute entered into an affiliation agreement and began its collaboration with each Home Institution in early 2022. Stanford University is a tax-exempt educational institution described in sections 501(c)(3) and 170(b)(1)(A)(ii) of the Code. Stanford Health Care, the university's hospital system, is a tax-exempt hospital described in sections 501(c)(3) and 170(b)(1)(A)(iii) of the Code. UCSF and UC Berkeley are tax-exempt educational institutions described in sections 501(c)(3) and 170(b)(1)(A)(ii) of the Code. UCSF (including its hospital system, UCSF Health) and UC Berkeley are part of the University of California system, which is a tax-exempt educational institution described in sections 501(c)(3) and 170(b)(1)(A)(ii) of the Code and an instrumentality of the state of California. | ExplanationTxt |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $78,510,616 | OtherCostOrOtherBasisAmt |
| Depreciation | $11,978,396 | DepreciationAmt |
| Book Value | $66,532,220 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $26,587,396 | OtherCostOrOtherBasisAmt |
| Depreciation | $6,742,659 | DepreciationAmt |
| Book Value | $19,844,737 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $86,376,957 | TotalBookValueLandBuildingsAmt |
Other Assets Org OtherAssetsOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | Right of Use Lease | Desc |
| Book Value | $50,518,248 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | $50,518,248 | TotalBookValueOtherAssetsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| Federal Income Taxes | |
| Lease liability | $58,640,256 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $58,640,256 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $122,280,682 | TotalRevEtcAuditedFinclStmtAmt |
| Other Revenue | $0 | OtherRevenueAmt |
| Revenue Not Reported | $0 | RevenueNotReportedAmt |
| Revenue Subtotal | $122,280,682 | RevenueSubtotalAmt |
| Other Revenues Not Included | $0 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | $0 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $122,280,682 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $83,444,377 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $662,521 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $662,521 | ExpensesNotReportedAmt |
| Expenses Subtotal | $82,781,856 | ExpensesSubtotalAmt |
| Other Expenses Not Included | $0 | OtherExpensesNotIncludedAmt |
| Expenses Not Rpt Fincl Stmt | $0 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $82,781,856 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote | The Institute qualifies as a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code and has been classified as a Medical Research Organization under Section 170(b)(1)(A)(iii). The Institute has adopted accounting guidance related to accounting for uncertainty in income taxes. This guidance requires the Institute to recognize a tax benefit only if it is more likely than not the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50 percent likely of being realized on examination. For tax positions not meeting the more-likely-than-not test, no tax benefit is recorded. The Institute has examined this issue and has determined there are no material contingent liabilities or questionable tax positions. The Institute does not expect the total amount of unrecognized tax benefits to significantly change in the next 12 months. The Institute recognizes interest and/or penalties to income tax matters in income tax expense. The Institute did not have any amounts accrued for interest and penalties as of December 31, 2024. |
| Schedule D, Part XII, Line 2(d) Other expenses in audited financial statements not in form 990 | REVERSAL OF GRANT FUNDS - 662521 |
Schedule F IRS990ScheduleF
Account Activities Outside US AccountActivitiesOutsideUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | North America (Canada & Mexico only) | RegionTxt |
| Offices | 0 | OfficesCnt |
| Employee | 1 | EmployeeCnt |
| Type Of Activities Conducted | Salaries and wages | TypeOfActivitiesConductedTxt |
| Region Total Expenditures | $150,762 | RegionTotalExpendituresAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 1 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 1 | TotalEmployeeCnt |
| Subtotal Spent | $150,762 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $150,762 | TotalSpentAmt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | false | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements | FormAndLineReferenceDesc |
| Explanation | NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (7 entries)
| Address Line1USAddress/AddressLine1Txt | Address Line2USAddress/AddressLine2Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|
| Stanford University | ||||||||
| Attn Joel Shaeffer Med School | 1/F 1265 Welch Road Mail Code 5404 | Stanford | CA | 943055101 | 941156365 | 501(c)(3) | $3,794,924 | University Fellowships |
| University of California San Francisco | ||||||||
| Attn Luke Gilbert PhD | UCSFBOX 0815 SUITE 425 | San Francisco | CA | 941430000 | 941156628 | 501(c)(3) | $4,000,000 | Goldberg-Benioff Endowed Professorship in Prostate Cancer Translational Biology |
| Stanford University | ||||||||
| 1/F 1265 Welch Road Mail Code 5404 | Stanford | CA | 943055101 | 941156365 | 501(c)(3) | $1,330,409 | Innovation Investigator | |
| University of California San Francisco | ||||||||
| UCSFBOX 0815 SUITE 425 | SAN FRANCISCO | CA | 941430000 | 946036493 | 501(c)(3) | $1,265,000 | Innovation Investigator | |
| University of California San Francisco | ||||||||
| UCSFBOX 0815 SUITE 425 | SAN FRANCISCO | CA | 941430000 | 946036493 | 501(c)(3) | $110,000 | Ignite awards | |
| UNIVERSITY OF CALIFORNIA BERKELEY | ||||||||
| 2195 HEARST AVE RM 120 MC 1104 | BERKELEY | CA | 947201083 | 946002123 | 501(c)(3) | $605,000 | Innovation Investigator | |
| UNIVERSITY OF CALIFORNIA BERKELEY | ||||||||
| 2195 HEARST AVE RM 120 MC 1104 | BERKELEY | CA | 947201083 | 946002123 | 501(c)(3) | $157,500 | Funds to cover the cost of a UCB instructor not teaching classes | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 3 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds | FormAndLineReferenceDesc |
| Explanation | University Fellowships to Stanford University to support PHD students pursuing degrees in science areas relating to Arc's mission. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Idemnification Gross Up Pmts | Yes (X) | IdemnificationGrossUpPmtsInd |
| Written Policy Ref T And E Expnss | Yes (true) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (true) | SubstantiationRequiredInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alden J Woodrow | ||||||||||||||
| CHIEF OPERATING OFFICER | $380,749 | $0 | $720,000 | $0 | $41,051 | $0 | $17,000 | $0 | $58,116 | $0 | $1,216,916 | $0 | $0 | $0 |
| Julia M Kazaks | ||||||||||||||
| GENERAL COUNSEL/ SECRETARY | $334,663 | $0 | $143,000 | $0 | $1,076 | $0 | $17,250 | $0 | $53,878 | $0 | $549,867 | $0 | $0 | $0 |
| Patrick D Hsu PhD | ||||||||||||||
| Core Investigator/ Co-Founder | $464,075 | $0 | $4,043 | $0 | $21,077 | $0 | $17,250 | $0 | $22,191 | $0 | $528,636 | $0 | $0 | $0 |
| Lynn M Hendrickson | ||||||||||||||
| UNIVERSITY RELATIONS & ACADEMIC AFFAIRS/ COMPLIANCE OFFICER | $267,311 | $0 | $75,630 | $0 | $1,103 | $0 | $14,420 | $0 | $60,351 | $0 | $418,815 | $0 | $0 | $0 |
| Therese A Costello | ||||||||||||||
| Head of People | $291,449 | $0 | $57,600 | $0 | $3,102 | $0 | $6,204 | $0 | $1,709 | $0 | $360,064 | $0 | $0 | $0 |
| Nicolle D Seuss | ||||||||||||||
| Senior Operations Program Manager | $236,962 | $0 | $51,990 | $0 | $1,382 | $0 | $14,815 | $0 | $37,291 | $0 | $342,440 | $0 | $0 | $0 |
| Silvana M Konermann PhD | ||||||||||||||
| EXECUTIVE DIRECTOR/ PRESIDENT | $211,402 | $0 | $33,660 | $0 | $512 | $0 | $0 | $0 | $18,972 | $0 | $264,546 | $0 | $0 | $0 |
| Susan T Cull | ||||||||||||||
| SENIOR FINANCE MANAGER | $163,520 | $0 | $25,410 | $0 | $303 | $0 | $9,231 | $0 | $662 | $0 | $199,126 | $0 | $0 | $0 |
| Michael K Teng | ||||||||||||||
| HEAD OF FINANCE/ TREASURER (AS OF 7/01/2024) | $150,482 | $0 | $400 | $0 | $124 | $0 | $7,693 | $0 | $29,418 | $0 | $188,117 | $0 | $0 | $0 |
| Yusuf H Roohani PHD | ||||||||||||||
| Group lead, machine learning | $111,440 | $0 | $295,900 | $0 | $89 | $0 | $4,950 | $0 | $32,392 | $0 | $444,771 | $0 | $0 | $0 |
| Nianzhen Li PHD | ||||||||||||||
| Senior Director, Multi-omics technology development | $291,705 | $0 | $98,180 | $0 | $1,555 | $0 | $6,702 | $0 | $1,900 | $0 | $400,042 | $0 | $0 | $0 |
| Lingyin Li PHD | ||||||||||||||
| Core Investigator | $255,752 | $0 | $76,400 | $0 | $1,573 | $0 | $2,677 | $0 | $21,404 | $0 | $357,806 | $0 | $0 | $0 |
| Hani Goodarzi PHD | ||||||||||||||
| CORE INVESTIGATOR | $225,107 | $0 | $28,167 | $0 | $20,389 | $0 | $10,108 | $0 | $36,793 | $0 | $320,564 | $0 | $0 | $0 |
| Luke A Gilbert PHD | ||||||||||||||
| CORE INVESTIGATOR | $245,502 | $0 | $0 | $0 | $16,906 | $0 | $13,067 | $0 | $19,062 | $0 | $294,537 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule J, Part I, Line 1a Tax indemnification and gross-up payments | THE FOLLOWING INDIVIDUALS RECEIVED A TAXABLE GROSS-UP PAYMENT DURING 2024 (INCLUDED IN SCHEDULE J, PART II, COLUMN (B)(III): Alden Woodrow Julia Kazaks Nicolle Seuss Patrick Hsu, PHD Lynn Hendrickson Therese Costello Nianzhen Li, PHD Lingyin Li, PHD |
| Schedule J, Part I, Line 4a Severance or change-of-control payment | THE FOLLOWING INDIVIDUALS RECEIVED SEVERANCE PAY DURING 2024 (INCLUDED IN SCHEDULE J, PART II, COLUMN (B)(III): DANIEL DEVER, PHD - $38,462 |
| Schedule J, Part I, Line 7 Non-fixed payments | For each full year of employment with the Institute, individuals shall be eligible to earn an annual bonus of up to a percentage of their effective Base Salary ("Annual Bonus"), based half on their and half on the Institute's achievement of performance goals established in advance by the Board of Directors of the Institute ("Board") or its delegate and provided in writing, contingent on the individuals remaining actively employed with the Institute through the payment date of each Annual Bonus. The Annual Bonus will be prorated based on start date. The Annual Bonus, if any, will be earned and paid no later than two and a half months after the end of the fiscal year, at which point the Board (or its delegate) will also have determined goals for the then current fiscal year. All bonus payments shall be made less deductions and withholdings required by law or approved by the individuals. COO Bonus program: For each year of employment with the Institute, the COO shall be eligible to earn a discretionary bonus, on a semi-annual basis, in the target amount of 50% of their then effective Base Salary, based on: (a) the extent of their achievement against individual performance goals set for each semi-annual period, and (b) overall performance rating for that semi-annual period ("Individual Performance Bonus"). The goals for each bonus period will be mutually agreed upon between the COO and the Institute and provided in writing. In each semi-annual period, if the COO achieves the goals and receives a performance rating of "3 - Exemplary," they will be eligible for the target bonus amount (50% of Base Salary). If they achieve fewer than all goals or receive a performance rating of "2 - Success," they will be eligible for a partial bonus in an amount deemed appropriate for the level of performance. If they receive a performance rating of "1 - Missed Expectations," they will not be eligible for any bonus for the period. Decisions concerning performance ratings, whether they receive an Individual Performance Bonus in any semi-annual period, and the amount of any such bonus, shall be at the Institute's discretion. Each Individual Performance Bonus, if awarded, will be paid by April 30 or October 31, as applicable. Eligibility to receive any Individual Performance Bonus payment is contingent upon the COO remaining actively employed with the Institute through the scheduled payment date. All bonus payments will be made less deductions and withholdings required by law or approved by the COO. |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (10 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Form 990, Part VI, Line 15b Process to establish compensation | Compensation is reviewed and approved by the Executive Director, COO, and Head of People. Radford survey data was used to determine compensation ranges, as well as publicly available data and compensation policies from Stanford and the University of California system. All deliberations and decisions are documented. |
| Form 990, Part VI, Line 15a Process to establish compensation for top management official | Compensation, including benefits, is reviewed and approved by the board for the executive director to ensure that it is just and reasonable. This occurs upon hiring, term renewal/extension (when applicable), and whenever the officer's compensation is modified, unless there is a universal modification of compensation that extends to substantially all employees. Arc engaged a compensation consultant in 2021 who completed a compensation survey to give an opinion to determine the appropriate compensation of the executive director, which was approved by the board. Comparability data was used from the survey to determine compensation ranges, as well as publicly available data and compensation policies from Stanford and the University of California system. All compensation increases must be approved by the board and are documented accordingly. |
| Form 990, Part VI, Line 6 Classes of members or stockholders | The Institute has, and will only have, one member at a time. The Member shall serve until the Member's death, incapacity or resignation. The Member and each successive Member shall name his/her successor. If at any time there is no Member serving and no successor has been designated, the Board of Directors shall designate the Member. |
| Form 990, Part VI, Line 7a Members or stockholders electing members of governing body | The Board of Directors shall be elected or appointed by the Member. The Member may remove and replace any member of the Board of Directors at any time for any or no reason. |
| Form 990, Part VI, Line 7b Decisions requiring approval by members or stockholders | The member has the following governing powers: -The annual meeting of the Member for the election of directors and for the transaction of such other business as may properly come before the meeting shall be held at such date, time and place, if any, as shall be determined by the Board of Directors and stated in the notice of the meeting. -Special meetings of the Member for any purpose or purposes shall be called pursuant to a resolution approved by the Board of Directors and may be called by the Member. The only business which may be conducted at a special meeting shall be the matter or matters set forth in the notice of such meeting. -Any meeting of the Member, annual or special, may be adjourned from time to time to reconvene at the same or some other place, if any, and notice need not be given of any such adjourned meeting if the time, place, if any, thereof, and the means of remote communication, if any, are announced at the meeting at which the adjournment is taken. At the adjourned meeting, the Corporation may transact any business which might have been transacted at the original meeting. If after the adjournment a new record date is fixed for the Member at the adjourned meeting, the Board of Directors shall fix a new record date for notice of the adjourned meeting and shall give notice of the adjourned meeting to the Member. -Notice of the place, if any, date, hour, and means of remote communication, if any, of every meeting of the Member shall be given by the Corporation not less than 10 days nor more than 60 days before the meeting (unless a different time is specified by law) to the Member. Notices of special meetings shall also specify the purpose or purposes for which the meeting has been called. Notices of meetings to the Member may be given by mailing the same, addressed to the Member, at the Member's mailing address as it appears on the records of the corporation and such notice shall be deemed to be given when deposited in the U.S. mail, postage prepaid. Without limiting the manner by which notices of meetings otherwise may be given effectively to the Member, any such notice may be given by electronic transmission in accordance with applicable law. For purposes of these bylaws, "electronic transmission" means any form of communication, not directly involving the physical transmission of paper, that creates a record that may be retained, retrieved, and reviewed by a recipient thereof, and that may be directly reproduced in paper form by such a recipient through an automated process. -The Board of Directors may adopt by resolution with the approval of the Member such rules and regulations for the conduct of the meeting of the Member as it shall deem appropriate. At every meeting of the Member, the Member, or in his/her absence or inability to act, such other officer or person appointed by the Member, shall act as chair of, and preside at, the meeting. The secretary or, in his/her absence or inability to act, the person whom the chair of the meeting shall appoint secretary of the meeting, shall act as secretary of the meeting and keep the minutes thereof. Except to the extent inconsistent with such rules and regulations as adopted by the Board of Directors, the chair of any meeting shall have the right and authority to prescribe such rules, regulations, and procedures and to do all such acts as, in the judgment of such chair, are appropriate for the proper conduct of the meeting. Such rules, regulations, or procedures, whether adopted by the Board of Directors with approval of the Member or prescribed by the chair of the meeting, may include, without limitation, the following: (a) the establishment of an agenda or order of business for the meeting; and (b) rules and procedures for maintaining order at the meeting and the safety of those present. Meetings of the Member may be held by means of telephone conference or other communications equipment by means of which all persons participating in the meeting can hear each other and be heard. -Any action to be taken at any annual or special meeting of the Member may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing or by electronic transmission, setting forth the action to be so taken, shall be signed by the Member and shall be delivered to the Corporation by delivery to its registered office in the State of Delaware (by hand or by certified or registered mail, return receipt requested), its principal place of business, an officer or agent of the Corporation having custody of the book in which proceedings of meetings of the Member are recorded, or to an information processing system designated by the corporation for receiving such consents in accordance with applicable law. Every consent shall bear the date of signature of the Member. -The Board of Directors shall be elected or appointed by the Member. The Member may remove and replace any member of the Board of Directors at any time for any or no reason. |
| Form 990, Part VI, Line 8b Documentation of meetings held by committees of governing body | THERE IS NO COMMITTEE WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY, SO THIS QUESTION HAS BEEN INTENTIONALLY ANSWERED "NO." |
| Form 990, Part VI, Line 11b Review of form 990 by governing body | THE FORM 990 AND SUPPLEMENTAL SCHEDULES ARE PREPARED AND REVIEWED BY AN EXTERNAL ACCOUNTING FIRM. IT IS THEN REVIEWED INTERNALLY BY MANAGEMENT and the audit committee. A COMPLETE COPY OF THE FORM IS PROVIDED TO ALL MEMBERS OF THE BOARD OF DIRECTORS AND AUDIT COMMITTEE AND THEY ARE REQUESTED TO REVIEW AND SUBMIT ANY QUESTIONS prior to filing. |
| Form 990, Part VI, Line 12c Conflict of interest policy | The Institute has a conflict of interest policy that requires directors, officers, key employees and other designated individuals to disclose if they have a personal interest or relationship in a transaction involving the Institute, whether directly or indirectly through a family member, controlled entity or business or investment relationship. Any individual with a personal interest or relationship in a transaction involving the Institute must be recused from the discussions and approval for that transaction. The transaction must be reviewed by disinterested persons who do not have a personal interest in the transaction under review, and such disinterested persons may approve the transaction after determining that the terms are fair and reasonable to the Institute. |
| Form 990, Part VI, Line 19 Required documents available to the public | THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. |
| Form 990, Part XI, Line 9 Other changes in net assets or fund balances | REVERSAL OF GRANT FUNDS - -662521; Total - -662521; |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ARC MOBILITY LLC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3181 PORTER DRIVE | AddressLine1Txt |
| City | PALO ALTO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 94304 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Primary Activities | TRANSPORTATION | PrimaryActivitiesTxt |
| Legal Domicile State | DE | LegalDomicileStateCd |
| Total Income | $0 | TotalIncomeAmt |
| End Of Year Assets | $0 | EndOfYearAssetsAmt |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ARC RESEARCH INSTITUTE | BusinessNameLine1Txt |